Breast tenderness after initiation of conjugated equine estrogens and mammographic density change

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 969-979

  Crandall, Carolyn J ^a   Aragaki, Aaron K ^b   Cauley, Jane A ^c   McTiernan, Anne ^b   Manson, Joann E ^d   Anderson, Garnet L ^b   Wactawski Wende, Jean ^e   Chlebowski, Rowan T ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Breast density; Breast tenderness; Conjugated equine estrogen; Mammographic density; Mastalgia; Mastodynia; Medroxyprogesterone acetate

Indexed keywords

CONJUGATED ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; ARTICLE; BREAST CANCER; BREAST TENDERNESS; CANCER RISK; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HORMONAL THERAPY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MONOTHERAPY; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR;

AGED; ESTROGENS, CONJUGATED (USP); FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MASTODYNIA; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK;

EID: 84856224687     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1803-9     Document Type: Article

References (42)

1. Brunner RL, Aragaki A, Barnabei V, Cochrane BB, Gass M, Hendrix S, Lane D, Ockene J, Woods NF, Yasmeen S, Stefanick M (2010) Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause (New York, NY. doi: 10.1097/gme.0b013e3181d76953
2. CJ Crandall A Karlamangla MH Huang G Ursin M Guan GA Greendale 2006 Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy Arch Intern Med 166 15 1578 1584 16908790 10.1001/archinte.166.15.1578 1:CAS:528:DC%2BD28XpsFGntro%3D
3. WH Utian D Shoupe G Bachmann JV Pinkerton JH Pickar 2001 Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate Fertil Steril 75 6 1065 1079 11384629 10.1016/S0015-0282(01)01791-5 1:STN:280:DC%2BD3MzhtFynsA%3D%3D
4. J Huber S Palacios L Berglund W Hanggi SM Sathanandan S Christau F Helmond 2002 Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women Bjog 109 8 886 893 12197367 10.1111/j.1471-0528.2002.01338.x 1:CAS:528:DC%2BD38Xls1WisLc%3D
5. Welton AJ, Vickers MR, Kim J, Ford D, Lawton BA, MacLennan AH, Meredith SK, Martin J, Meade TW (2008) Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ (Clinical research ed 337:a1190
6. VM Barnabei BB Cochrane AK Aragaki I Nygaard RS Williams PG McGovern RL Young EC Wells MJ O'Sullivan B Chen R Schenken SR Johnson 2005 Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative Obstet Gynecol 105 5 Pt 1 1063 1073 15863546 10.1097/01.AOG.0000158120.47542.18 1:CAS:528:DC%2BD2MXksValtrY%3D
7. A McTiernan CF Martin JD Peck AK Aragaki RT Chlebowski ED Pisano CY Wang RL Brunner KC Johnson JE Manson CE Lewis JM Kotchen BS Hulka 2005 Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial J Natl Cancer Inst 97 18 1366 1376 16174858 10.1093/jnci/dji279 1:CAS:528:DC%2BD2MXhtVKhsrjP
8. GA Greendale BA Reboussin S Slone C Wasilauskas MC Pike G Ursin 2003 Postmenopausal hormone therapy and change in mammographic density J Natl Cancer Inst 95 1 30 37 12509398 10.1093/jnci/95.1.30 1:CAS:528:DC%2BD3sXitlOnt74%3D
9. NF Boyd JW Byng RA Jong EK Fishell LE Little AB Miller GA Lockwood DL Tritchler MJ Yaffe 1995 Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study J Natl Cancer Inst 87 9 670 675 7752271 10.1093/jnci/87.9.670 1:STN:280:DyaK2M3ntFOjsg%3D%3D
10. McTiernan A, Chlebowski RT, Martin C, Peck JD, Aragaki A, Pisano ED, Wang CY, Johnson KC, Manson JE, Wallace RB, Vitolins MZ, Heiss G (2009) Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the Women's Health Initiative randomized trial. J Clin Oncol. doi: 10.1200/JCO.2008.21.7166
11. American Cancer Society (2010) Cancer facts & figures 2010. Atlanta
12. SR Wellings JN Wolfe 1978 Correlative studies of the histological and radiographic appearance of the breast parenchyma Radiology 129 2 299 306 704841 1:STN:280:DyaE1M%2FjsVentA%3D%3D
13. RA Bright AS Morrison J Brisson NA Burstein NS Sadowsky DB Kopans JE Meyer 1988 Relationship between mammographic and histologic features of breast tissue in women with benign biopsies Cancer 61 2 266 271 3334961 10.1002/1097-0142(19880115)61:2<266::AID-CNCR2820610212>3.0.CO;2-N 1:STN:280:DyaL1c%2FnvFyqsg%3D%3D
14. NH Bulbul S Ozden V Dayicioglu 2003 Effects of hormone replacement therapy on mammographic findings Arch Gynecol Obstet 268 1 5 8 12673467
15. MM McNicholas JP Heneghan MH Milner T Tunney JB Hourihane DP MacErlaine 1994 Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study AJR Am J Roentgenol 163 2 311 315 8037021 1:STN:280:DyaK2czhtFWisg%3D%3D
16. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group (1998). Controlled clinical trials 19(1):61-109
17. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial Jama 288 3 321 333 12117397 10.1001/jama.288.3.321 1:CAS:528:DC%2BD38Xltlegs7k%3D
18. GL Anderson M Limacher AR Assaf T Bassford SA Beresford H Black D Bonds R Brunner R Brzyski B Caan R Chlebowski D Curb M Gass J Hays G Heiss S Hendrix BV Howard J Hsia A Hubbell R Jackson KC Johnson H Judd JM Kotchen L Kuller AZ LaCroix D Lane RD Langer N Lasser CE Lewis J Manson K Margolis J Ockene MJ O'Sullivan L Phillips RL Prentice C Ritenbaugh J Robbins JE Rossouw G Sarto ML Stefanick L Van Horn J Wactawski-Wende R Wallace S Wassertheil-Smoller 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial Jama 291 14 1701 1712 15082697 10.1001/jama.291.14.1775 1:CAS:528:DC%2BD2cXjt1WktLw%3D
19. RT Chlebowski SL Hendrix RD Langer ML Stefanick M Gass D Lane RJ Rodabough MA Gilligan MG Cyr CA Thomson J Khandekar H Petrovitch A McTiernan 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial Jama 289 24 3243 3253 12824205 10.1001/jama.289.24.3243 1:CAS:528: DC%2BD3sXkvVOktbg%3D
20. RT Chlebowski G Anderson JE Manson M Pettinger S Yasmeen D Lane RD Langer FA Hubbell A McTiernan S Hendrix R Schenken ML Stefanick 2010 Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy J Clin Oncol 28 16 2690 2697 10.1200/JCO.2009.24.8799 20439627 10.1200/JCO.2009.24.8799
21. PA Ganz R Day JE Ware Jr C Redmond B Fisher 1995 Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial J Natl Cancer Inst 87 18 1372 1382 7658498 10.1093/jnci/87.18.1372 1:STN:280:DyaK2MzoslChsQ%3D%3D
22. GA Greendale BA Reboussin P Hogan VM Barnabei S Shumaker S Johnson E Barrett-Connor 1998 Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial Obstet Gynecol 92 6 982 988 9840563 10.1016/S0029-7844(98)00305-6 1:CAS:528: DyaK1cXotVKgsr4%3D
23. C Martin J Peck E Pisano C Davis A McTiernan B Hulka 2000 Prior hrt use, ethnicity and mammographic density Ann Epidemiol 10 7 461 462 11018375 10.1016/S1047-2797(00)00157-5
24. CM Vachon CC Kuni K Anderson VE Anderson TA Sellers 2000 Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) Cancer Causes Control 11 7 653 662 10977110 10.1023/A:1008926607428 1:STN:280:DC%2BD3M7ht1CrtA%3D%3D
25. AY El-Bastawissi E White MT Mandelson S Taplin 2001 Variation in mammographic breast density by race Ann Epidemiol 11 4 257 263 11306344 10.1016/S1047-2797(00)00225-8 1:STN:280:DC%2BD3MzntVansA%3D%3D
26. N Boyd L Martin J Stone L Little S Minkin M Yaffe 2002 A longitudinal study of the effects of menopause on mammographic features Cancer Epidemiol Biomarkers Prev 11 10 Pt 1 1048 1053 12376506
27. SM Gapstur P Lopez LA Colangelo J Wolfman L Van Horn RE Hendrick 2003 Associations of breast cancer risk factors with breast density in Hispanic women Cancer Epidemiol Biomarkers Prev 12 10 1074 1080 14578145
28. P Lopez L Van Horn LA Colangelo JA Wolfman RE Hendrick SM Gapstur 2003 Physical inactivity and percent breast density among Hispanic women Int J Cancer 107 6 1012 1016 14601063 10.1002/ijc.11495 1:CAS:528:DC%2BD3sXptFOgtbs%3D
29. D Heng F Gao R Jong E Fishell M Yaffe L Martin T Li J Stone L Sun J Hopper NF Boyd 2004 Risk factors for breast cancer associated with mammographic features in Singaporean chinese women Cancer Epidemiol Biomarkers Prev 13 11 Pt 1 1751 1758 15533903
30. M Jeffreys R Warren D Gunnell P McCarron GD Smith 2004 Life course breast cancer risk factors and adult breast density (United Kingdom) Cancer Causes Control 15 9 947 955 15577297
31. M Hofling K Carlstrom G Svane E Azavedo H Kloosterboer B Von Schoultz 2005 Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels-an association with mammographic density Gynecol Endocrinol 20 2 110 115 15823831 10.1080/09513590400021151 1:CAS:528:DC%2BD2MXjtFCksbg%3D
32. E Riza I Dos Santos Silva B De Stavola N Perry E Karadedou-Zafiriadou D Linos DD Remoundos A Linos 2005 Correlates of high-density mammographic parenchymal patterns by menopausal status in a rural population in Northern Greece Eur J Cancer 41 4 590 600 15737565 10.1016/j.ejca.2004.12.014
33. G Maskarinec I Pagano G Lurie LN Kolonel 2006 A longitudinal investigation of mammographic density: the multiethnic cohort Cancer Epidemiol Biomarkers Prev 15 4 732 739 10.1158/1055-9965.EPI-05-0798 16614116 10.1158/1055-9965.EPI-05-0798
34. L Titus-Ernstoff AN Tosteson C Kasales J Weiss M Goodrich EE Hatch PA Carney 2006 Breast cancer risk factors in relation to breast density (United States) Cancer Causes Control 17 10 1281 1290 10.1007/s10552-006-0071-1 17111260 10.1007/s10552-006-0071-1
35. MR Palomares JR Machia CD Lehman JR Daling A McTiernan 2006 Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors Cancer Epidemiol Biomarkers Prev 15 7 1324 1330 16835331 10.1158/1055-9965.EPI-05-0689
36. C Byrne C Schairer J Wolfe N Parekh M Salane LA Brinton R Hoover R Haile 1995 Mammographic features and breast cancer risk: effects with time, age, and menopause status J Natl Cancer Inst 87 21 1622 1629 7563205 10.1093/jnci/87.21. 1622 1:STN:280:DyaK28%2Fis1aluw%3D%3D
37. RL Prentice RT Chlebowski ML Stefanick JE Manson RD Langer M Pettinger SL Hendrix FA Hubbell C Kooperberg LH Kuller DS Lane A McTiernan MJ O'Sullivan JE Rossouw GL Anderson 2008 Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study Am J Epidemiol 167 12 1407 1415 10.1093/aje/kwn090 18448442 10.1093/aje/kwn090
38. Chlebowski RT, Anderson G, Pettinger M, Lane D, Langer RD, Gilligan MA, Walsh BW, Chen C, McTiernan A (2008) Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Archives of internal medicine 168 (4):370-377; quiz 345. doi: 10.1001/archinternmed.2007.123
39. RL Prentice RT Chlebowski ML Stefanick JE Manson M Pettinger SL Hendrix FA Hubbell C Kooperberg LH Kuller DS Lane A McTiernan M Jo O'Sullivan JE Rossouw GL Anderson 2008 Estrogen plus progestin therapy and breast cancer in recently postmenopausal women Am J Epidemiol 167 10 1207 1216 10.1093/aje/kwn044 18372396 10.1093/aje/kwn044
40. ML Stefanick GL Anderson KL Margolis SL Hendrix RJ Rodabough ED Paskett DS Lane FA Hubbell AR Assaf GE Sarto RS Schenken S Yasmeen L Lessin RT Chlebowski 2006 Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy Jama 295 14 1647 1657 16609086 10.1001/jama.295.14.1647 1:CAS:528:DC%2BD28XjsVeqsrY%3D
41. JD Yager NE Davidson 2006 Estrogen carcinogenesis in breast cancer N Engl J Med 354 3 270 282 10.1056/NEJMra050776 16421368 10.1056/NEJMra050776 1:CAS:528:DC%2BD28Xls1KjtQ%3D%3D
42. Schramek D, Sigl V, Penninger JM (2011) RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. Trends Endocrinol Metab. doi: 10.1016/j.tem.2011.02.007